The U.S. Food and Drug Administration approved two medications in June that may benefit long-term care patients.
The Food and Drug Administration announced last week that the sleep drug Lunesta should be started at a lower dose.
Nursing homes now have new guidance about using certain types of reprocessed medical devices, the Centers for Medicare & Medicaid Services announced.
A recent $4 million legal settlement over kickbacks for anemia drug Aranesp is small change compared to other recent deals Omnicare has made with federal authorities. News of these payouts hasn't escaped long-term care pharmacy investors, some of whom filed their own charges against the pharmacy provider, launching a case that is now set to be heard by the U.S. Supreme Court.
Nursing homes should ensure they are not serving potentially hazardous Uncle Ben's brand rice products, the Food and Drug Administration has announced.
The Food and Drug Administration has issued final guidance on mobile medical apps.
The U.S. Food and Drug Administration has announced it will seek restricted access to hydrocodone painkillers, prompting a concerned response from long-term care stakeholders.
The Food and Drug Administration on Friday approved a lipid injectable emulsion called Clinolipid for parenteral nutrition in adult patients.
Statins, which are commonly used to treat high cholesterol, do not cause cognition problems in the short term and may offer significant protection against dementia in the long term. This is according to new research that contradicts government warnings about these medications.
Certain Medtronic MiniMed Paradigm Insulin Infusion sets are being recalled, the Food and Drug Administration announced on Friday.
Two asthma inhalers are being phased out, the Food and Drug Administration announced at the end of May.
Every few days I read the Food and Drug Administration (FDA) news to see if there is anything relevant to eldercare that I should be aware of. Recently, I came across an extremely eye-opening item.
The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.
Long-term care residents who experience constipation from taking opioids to manage chronic pain may benefit from Amitiza, an oral drug recently approved by the Food and Drug Administration.
Pfizer must pay $142 million for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a federal appeals court has ruled.
The Food and Drug Administration should "act without delay" in tightening access to hydrocodone painkillers such as Vicodin, Congressional lawmakers urged in a recent letter. The letter was written by Sen. Joe Manchin (D-WV) and signed by a bipartisan group of five other senators and two representatives.
There are some people who are able to fall asleep as their head is hitting the pillow. Then there are the rest of us. And if you don't think you know any of us, you're probably wrong.
The Food and Drug Administration is requiring manufacturers of certain sleeping pills, including the widely prescribed Ambien, to reduce current recommended dosages.
Invacare has signed a consent decree in which the company will fix wheelchair manufacturing problems, the Food and Drug Administration announced.
The unapproved bed sore drug Xenaderm, which was marketed to nursing homes as "Medicaid reimbursed," is the source of a settlement that could reach $48 million for Healthpoint Ltd. and DFB Pharmaceuticals.
GlaxoSmithKline will pay a $90 million settlement to 38 states that claimed it unlawfully promoted its diabetes treatment Avandia (rosiglitazone). The attorneys general of several states confirmed the action on Thursday.
The aggressive marketing of power wheelchairs and scooters to seniors drives up Medicare costs and puts providers in a tough spot, says Sen. Richard Blumenthal (D-CT).
President Obama signed the Food and Drug Administration user fees bill into law on Monday. The measure reauthorizes user fees paid by medical device and drug companies and creates new user fee programs for generic drugs and bio-similar (or follow-on biologic) drugs. In addition, the measure creates regulatory provisions affecting drugs and devices. These include antibiotic development incentives, shortage prevention provisions and new guidance for related social media activities.
Companies that manufacture opioid painkillers must underwrite training and educational programs for the physicians who prescribe them, according to a new federal safety measures announced Monday.
The U.S. Senate did not approve legislation that would strengthen regulations for antipsychotic use in nursing homes, despite overwhelmingly passing a bill it was attached to on Thursday.
Having recently plunked down a $120 co-pay for medicine that was a far cry from designer caliber, I can relate to people who believe drugs are too expensive.
Makers of the Alzheimer's drug Aricept released a higher dosage version of the medication despite concerns about side effects and reduced efficacy, a study reports.
Medications given to treat anemia in kidney and cancer patients greatly increase the risk of cardiovascular problems and need to be used more conservatively, the Food and Drug Administration has said.
Atypical antipsychotic medications are no more dangerous than other conventional antipsychotics, antidepressants and benzodiazepines when it comes to treating nursing home residents, according to a new study.